Merck & Co., Inc. (MRK) vs Platinum Futures (PLATINUM)

See how Merck & Co., Inc. and Platinum Futures differ across market data and performance, so you can decide which asset best fits your strategy.

$143.37
NYSE
Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.
View Full Page
$1,405.1
NY Mercantile
Platinum Futures represent standardized exchange-traded contracts linked to the future price of platinum. They are used by producers, consumers, traders, and investors to hedge exposure, express views on supply and demand, or gain commodity-market exposure. Their price is influenced by auto-catalyst demand, jewelry demand, industrial use, mine supply, investor flows, and the U.S. dollar.
View Full Page

Key Metrics Comparison

Merck & Co., Inc.MRK
Market Cap
$353.442B
Price
$143.37
24h Change
-0.75%
24h Volume
$7.26M
Employees
73,000
Shares Outstanding
2,469,879,206
Platinum FuturesPLATINUM
Market Cap
$351.275B
Price
$1,405.1
24h Change
-1.50%
24h Volume
$2.8K
Employees
N/A
Shares Outstanding
N/A

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
MRK
50.2%
PLATINUM
49.8%

Volume Share

Share of combined 24h volume

Volume Share
MRK
100.0%
PLATINUM
1.0%

24h Performance

Price change over last 24 hours

24h Performance
MRK
-0.75%
PLATINUM
-1.50%
Price Comparison
Merck & Co., Inc.
Platinum Futures